IgG in dialysate may have an important role Introduction in anti-infection mechanisms during continuous ambulatory peritoneal dialysis (CAPD). As Fc fragment The role of humoral immunity in the local antioligosaccharidic chains are crucial for IgG effector infection defence mechanism during continuous ambufunctions, we have tested the hypothesis that IgG latory peritoneal dialysis (CAPD) is still not elucidated. glycation might occur during CAPD and modify IgG Some studies reported a relationship between a high properties. Purified normal IgG was incubated with peritonitis incidence and low IgG concentrations in glucose solutions of different concentrations and pH. effluent of overnight dialysis dwells [1,2] but such a Separation of glycated IgG was performed by affinity relationship could not be confirmed by other groups chromatography. Complement activation (C3c depos- [3] [4] [5] . IgG molecules contain polysaccharidic chains ition) and phagocytosis by polymorphonuclear leucowhich play an important role in the Fc fragment cytes (PMN) were studied in vitro using Staphylococcus functions, such as IgG plasmatic clearance by the liver aureus Wood (STAW ) as antigen. In addition, we asialoprotein receptors [6 ], complement activation [7 ] compared the percentages of glycated IgG in IgG and IgG binding to Fc receptors [8]. As glucose is still purified from sera and dialysates of 12 CAPD patients. the more commonly used osmotic agent in peritoneal The percentage of glycated IgG after in vitro incubation dialysis and as prolonged contact between glucose and of normal IgG with glucose solutions was directly proteins can lead to non-enzymatic glycation of the proportional to glucose concentrations, incubation latter [9], we tested in the present study the hypothesis time and pH. Glycated IgG anti-STAW induced a according to which the use of glucose in CAPD could higher C3c deposition than non-glycated IgG antiinduce the formation of glycated IgG and modify IgG STAW (C3c/IgG (mean±SD) 0.96±0.06 vs 0.79± ability to activate complement and promote phagocyt-0.08; P=0.027). PMN phagocytosis was not affected osis in dialysate. Studies were performed in vitro and by IgG glycation. The percentages of glycated IgG in in patients. dialysates of CAPD patients were greater than those in corresponding sera (5.38±2.36% vs 4.56±2.47%; P=0.006). It is concluded that IgG glycation may take place in the peritoneal cavity during CAPD and lead Subjects and methods to enhanced complement activation. This could explain the high degree of complement activation previously Patients and controls described in dialysate of CAPD patients and might theoretically result in a reduction of complement fac-Twelve stable adult CAPD patients aged from 18 to 57 years tors available in dialysate for adequate anti-infection were included in the study. They were treated with glucosemechanisms.
Blood samples and dialysates
were applied to gel chromatography columns containing m-aminophenylboric acid able to bind to glucose molecules. Dialysates from night dwells (7-11 h) were collected and Non-glycated IgG was eluted with a wash buffer without immediately stored at −20°C until determinations. Sera from sugars. Glycated IgG was then eluted from the columns patients with agammaglobulinaemia (and with normal haeusing a sorbitol-containing buffer. Glycated IgG percentages molytic complement activity) were used as source of complewere determined by measuring the absorbance at 280 nm of ment. All agammaglobulinaemic samples were stored at both fractions with a spectrophotometer. All measurements −70°C and thawed at 4°C just before use. Other serum were performed in duplicate. Within-run and between-day samples were flash-frozen and stored at −70°C. Serum variation coefficients were calculated using classical formulae, samples and corresponding night dwells were collected on and were always less than 10%. the same day.
Materials
IgG ELISA assay HRP-conjugated rabbit anti-human IgG and HRP-conjug-The IgG ELISA assay was performed as previously described ated anti-human C3c were purchased from Dako, Glostrup, by Rü mke et al. In vitro glycation containing 20 mmol/l Hepes, 132 mmol/l NaCl, 6 mmol/l KCl, 1.2 mmol/l KH 2 PO 4 , 1 mmol/l MgCl 2 , 1.5 mmol/l The influence of pH, glucose concentration and incubation EGTA (Merck-Schuchardt), 0.1% w/v gelatin and 5.6 mmol/l time on IgG glycation was studied using commercial 16% glucose, pH 7.4 (Ca2+-free Hepes), and adjusted to IgG preparations for intramuscular injections (CLB, 1×107 cells/ml. EGTA was added to this buffer to bind Amsterdam, The Netherlands). These were incubated at a free Ca2+, to prevent granulocyte aggregation during final concentration of 10 mg/ml at 37°C for varying times phagocytosis. with different glucose solutions (0.05, 0.2, 0.4 M) at different
To assay phagocytosis, we employed a flow cytometric pHs (5.5, 7, 9) both fractions showed no difference between glycated Results and non-glycated IgG fractions (data not shown).
In vitro IgG glycation
In vivo IgG glycation Using the modified Gluco Test 100 II method for separation of glycated from non-glycated IgG, in vitro The percentage of glycated IgG found in sera of 12 experiments of IgG incubation with glucose solutions CAPD patients was not statistically different from that at concentrations similar to those used for peritoneal found in five normal controls (4.56±2.47% vs dialysis treatment showed that the percentage of gly-4.34±1.36%). The values in sera of diabetic patients cated IgG was directly related to the pH and glucose (12.94±7.05%; P<0.001) were higher than those concentrations as well as to the incubation time found in normal controls. The percentages of glycated ( Figures 1 and 2 ) . For example, for a 0.2 M glucose IgG in overnight dwell dialysates of 12 CAPD patients solution at pH 9, the percentage of glycated IgG dialysed with 3.86% glucose solutions were significantly increased from 5% to 16% after 8 h, 40% after 24 h higher than those found in the corresponding sera, and 70% after 72 h ( Figure 1 ). After incubation times as shown in Figure 3 ( 5.38±2.36% vs 4.56±2.47%; of 8, 24 and 72 h with a 0.2 M glucose solution, the P=0.006). percentage of glycated IgG was 5, 12 and 29%, respectively at pH 7, and 5, 7 and 15% at pH 5.5 ( Figure 1 ). Glycated IgG functions Finally, for the same incubation time (72 h) and pH
The ability of IgG to bind specifically to antigens after ( 5.5), the percentage of glycated IgG was, respectively, glycation was tested using commercial 16% IgG (CLB, 20, 9 and 7% with 0.4, 0.2 and 0.05 M glucose solutions Amsterdam, The Netherlands) with high anti-STAW ( Figure 2 ). The analysis of IgG subclass content of antibody titres. After separation of glycated from nonglycated IgG, identical amounts of both fractions were applied to ELISA assays using STAW-coated plates. The amounts of IgG binding to the plates were similar for both fractions (data not shown). The ability of glycated and non-glycated IgG to activate the complement cascade was tested with the same ELISA system using agammaglobulinaemic sera as complement source. The local C3c deposition was measured and the results are expressed in C3c per IgG. Glycated IgG activated the complement cascade more than the corresponding non-glycated IgG in four different commercial IgG preparations, as shown in Figure 4 (C3c/IgG ratio: 0.96±0.06 vs 0.79±0.08; P=0.027). To specify the route of complement activation, the same experiments were performed in the presence of MgEGTA. according to these in vitro experiments, no increased IgG glycation should be expected in vivo. Indeed, significantly increased percentages of glycated IgG are observed only after at least 24 h incubations, whatever the experimental conditions, whereas maximal dwell times in vivo are about 11 h. The rapid increase of dialysate pH, which reaches physiological values half an hour after intra-abdominal infusion, does not explain this discrepancy [17] . This may be explained by the observation of Krediet et al. [18 ] , who demonstrated that the peritoneal interstitium may constitute a third compartment between blood and dialysate, in which equilibrium with blood and dialysate takes place for serum proteins. It may therefore be hypothesized that contact between glucose and IgG takes place in the latter compartment for periods longer than dwell times, allowing IgG glycation before its passage into Gerbitz [10] after in vitro glycation of IgG, we were surprised to find that glycated IgG separated from normal IgG induced more complement activation than of glycated and of non-glycated IgG was completely non-glycated IgG. The reasons for this discrepancy are abolished when 10 mmol/l MgEDTA was added to the unknown. However, in glycation, glucose reacts with wells (data not shown).
free amino groups of proteins to form labile Schiff bases, with subsequent Amadori rearrangement to Phagocytosis assay stable ketoamines. Formation of Amadori products is No differences were found between the percentages of well established for a number of proteins and has been green fluorescent PMN in the phagocytosis assay using found to be increased in diabetes (for a review see glycated or non-glycated IgG, with or without trypan [9]). The Amadori product very slowly undergoes a blue, and with a complement source (agammaglobuliseries of still unknown rearrangement reactions to naemic sera) (93.43±4.69% vs 91.4±6.11%; n=4, form yellow-brown, fluorescent and cross-linking sub-P>0.05) or without ( 35.2±2.63% vs 36.27±4.39%; stances, called advanced glycosylation end (AGE ) n=4, P>0.05).
products. These products are thought to accumulate on proteins and play an important role in the development of late diabetic complications (for a review see
Discussion
[19]). In the experiments of Dolhofer-Bliesener and Gerbitz [10 ], the experiment conditions ( long incubation time, high pH ) led to the formation of AGE Dolhoffer-Bliesener and Gerbitz [10] reported that IgG glycation may occur during in vitro incubation of IgG products as shown by the formation of non-enzymatic brown products revealed by measurement of absorp-with glucose solutions. Indeed, they showed increased IgG glycation after incubation of normal purified IgG tion at 350 nm and fluorescence at 440 nm upon excitation at 370 nm. Glycated IgG used in our experiments in glucose-containing solutions at concentrations ranging from 0.014 to 0.056 M, for 6 days at pH 9. As were most probably early glycosylation products.
Indeed, immunoreactivity for AGE products is not those incubation conditions were not comparable with those encountered in peritoneal dialysis, since pH 9 is increased and almost non-existant in IgG fractions purified from normal controls and diabetic patients not physiological and dwell times are shorter in CAPD, we have repeated those experiments using different because of a rapid clearance by mononuclear phagocytes receptors for AGE [20 ] . It is therefore conceiv-incubation times (8, 24, 72 h), different pH conditions ( 5.5, 7, 9 ) , and glucose concentrations similar to those able that, being chemically different, glycated IgG used in our experiments expresses different effector proper-used in commercially available CAPD solutions (0.05, 0.1, 0.2 M ). We have confirmed a direct relationship ties from those used by the latter authors. The more important complement activation by glycated IgG between the percentage of glycated IgG, glucose concentration and incubation time. Also, we have shown observed in our experiments is induced by the classical route, as shown by complete inhibition by MgEGTA, that the pH of the incubating solution is a major factor determining the degree of IgG glycation. Indeed, the and may be secondary to the increased capacity of glycated IgG to aggregate [10] . This hypothesis should percentage of glycated IgG was directly related to the pH of the solutions, being greatest at pH 9. However, be tested by comparing on gel chromatography
